Creative Planning’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$95.9K Buy
15,024
+556
+4% +$3.55K ﹤0.01% 3424
2025
Q1
$70.3K Sell
14,468
-1,532
-10% -$7.45K ﹤0.01% 3284
2024
Q4
$153K Sell
16,000
-442
-3% -$4.23K ﹤0.01% 3049
2024
Q3
$137K Sell
16,442
-1,326
-7% -$11.1K ﹤0.01% 2955
2024
Q2
$121K Buy
17,768
+3,720
+26% +$25.4K ﹤0.01% 2789
2024
Q1
$35.5K Buy
+14,048
New +$35.5K ﹤0.01% 2786
2021
Q3
Sell
-4,749
Closed -$299K 2068
2021
Q2
$299K Buy
4,749
+1,210
+34% +$76.2K ﹤0.01% 1558
2021
Q1
$329K Sell
3,539
-10,119
-74% -$941K ﹤0.01% 1709
2020
Q4
$1.22M Buy
13,658
+7,833
+134% +$702K ﹤0.01% 853
2020
Q3
$602K Buy
+5,825
New +$602K ﹤0.01% 1026
2017
Q3
Sell
-4,555
Closed -$154K 2307
2017
Q2
$154K Buy
4,555
+55
+1% +$1.86K ﹤0.01% 1657
2017
Q1
$131K Hold
4,500
﹤0.01% 1765
2016
Q4
$148K Sell
4,500
-5,600
-55% -$184K ﹤0.01% 1574
2016
Q3
$318K Buy
10,100
+6,000
+146% +$189K ﹤0.01% 1141
2016
Q2
$115K Sell
4,100
-65
-2% -$1.82K ﹤0.01% 1571
2016
Q1
$151K Sell
4,165
-35
-0.8% -$1.27K ﹤0.01% 1367
2015
Q4
$168K Sell
4,200
-18,900
-82% -$756K ﹤0.01% 1298
2015
Q3
$658K Buy
+23,100
New +$658K 0.01% 632
2015
Q2
Sell
-4,200
Closed -$121K 1532
2015
Q1
$121K Buy
4,200
+1,534
+58% +$44.2K ﹤0.01% 1461
2014
Q4
$73K Sell
2,666
-9,334
-78% -$256K ﹤0.01% 1723
2014
Q3
$256K Buy
12,000
+11,360
+1,775% +$242K ﹤0.01% 939
2014
Q2
$14K Buy
640
+350
+121% +$7.66K ﹤0.01% 2648
2014
Q1
$7K Hold
290
﹤0.01% 2855
2013
Q4
$7K Sell
290
-200
-41% -$4.83K ﹤0.01% 2709
2013
Q3
$9K Buy
+490
New +$9K ﹤0.01% 2496